from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1847/-

LFCtreatmentdescriptionclass of inhibitor

-1.172

Amikacinug/mL Amikacintranslation

-0.590

Cap5-10ug/mL Capreomycintranslation

-1.373

Rox10-50 ug/mL Roxithromycintranslation

-0.133

SM2-5 ug/mL Streptomycintranslation

-0.005

Tet5-10 ug/mL Tetracyclinetranslation

-0.184

Rif0.2-5ug/mL Rifampicintranscription

-0.011

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.003

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.558

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.613

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.445

Clofazimine10-13 ug/mL Clofaziminerespiration

0.283

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.652

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.260

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.588

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.087

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.603

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.666

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.012

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.231

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.334

KCN5-20 ug/mL Potassium cyaniderespiration

-0.163

NaN30.2-2 mM Sodium aziderespiration

0.020

Nigericin50 uM Nigericinrespiration

-0.261

TRC10-150 ug/mL Triclosanrespiration

-0.350

TRZ10-25 ug/mL Thioridazinerespiration

3.958

Valinomycin0.5-10 uM Valinomycinrespiration

1.393

ZnSO42 mM ZnSO4respiration

0.098

menadione6-10 ug/mL Menadionerespiration

0.301

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.132

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.752

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.209

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.156

NRP_1Non-replicating persistence stage 1dosRassociated

0.027

Amp0.2mg/mL AmpicillincellWall

0.238

Cephalexin20-100 ug/mL CephalexincellWall

-0.397

Cerulenin0.32-5 ug/mL CerulenincellWall

0.278

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.051

EMB10-20 ug/mL EthambutolcellWall

0.514

Eta12-40 ug/mL EthionamidecellWall

0.481

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.203

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.338

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.859

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.637

BZA0.12 mg/mL BenzamidearomaticAmides

0.086

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.267

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.692

H2O24 mM hydrogen peroxideDNAdamaging

-0.244

Levo10 ug/mL LevofloxacinDNAdamaging

-0.038

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.302

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.360

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.369

UVUV-irradiationDNAdamaging

0.892

ARP41-4 ug/mL Antitubercular compound ARP4?

0.207

Antimycin12.5-50 ug/mL Antimycin A?

0.609

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.005

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.367

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.921

PA8240.2-2 ug/mL PA-824?

-1.059

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.002

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.387

Verapamil50 uM Verapamil?

-0.007

mercaptoethanol2 mM 2-Mercaptoethanol?

0.139

methoxatin10-20 ug/mL Methoxatin?